MadmajPRO

Research

TodayDiscoverChat with Data (beta)

Workspace

WatchlistCompareHeatmapBacktest

Market

InsidersWhale Tracker
TodayDiscoverWatchlistAsk

Discover

Stocks our models think are worth a closer look, with the evidence behind each pick.

Updated October 6 from 5,257 stocks

Top ranked

Ranked by opportunitySince flagged
  • 4Rank 4 stays locked
  • 5Rank 5 stays locked
  • 6Rank 6 stays locked
  • 7Rank 7 stays locked
  • 8Rank 8 stays locked
  • 9Rank 9 stays locked
  • 10Rank 10 stays locked
Pro

5,254 more matches stay locked

The full book, filters, and recent snapshots open with Pro. New accounts get 14 days of Pro free.

Log in — 14 days free

Gyrodyne, LLC

GYRO, Real Estate, ranked #1

$4.43

−5.7% since flagged

Our view

Not a buy today. Fine to keep holding if you already own it.

The company is described as specializing in medical office properties and providing customer service. No evidence establishes its market share, relative performance, or advantages over competitors.

Main risk: Revenue sources, recurrence, growth, profitability, and cash generation are not established.

Held: the verdict explanation failed its checks, so the action is Hold

Evidence coverage52%

Insufficient

Conviction15%

Low

Why it ranks now

No current catalyst is available for this stock.

Analyst target

—

Not reported

Open full analysis

Research only. Not a buy order and not personal advice. Check the filings, the price, and your own risk before you act.